Director/PDMR Shareholding

Plant Health Care PLC
02 April 2008


Plant Health Care plc
2 April 2008

For immediate release                                              2 April 2008

                     PLANT HEALTH CARE plc (THE 'COMPANY')

1) ALLOTMENT OF SHARES/ DIRECTORS' SHAREHOLDINGS

2) VESTING OF SHARES UNDER 2007 LONG TERM INCENTIVE PLAN ('LTIP')

3) GRANT OF AWARD UNDER 2007 LONG TERM INCENTIVE PLAN

1) On 1 April 2008, the Company approved the allotment of 7,569 ordinary shares
of 1p ('Ordinary Shares') to the following non-executive directors, in
accordance with the Company's existing contractual arrangements, which comprise
part of the non-executive directors' remuneration packages and are payable in
lieu of a part of their salary. The shares were allotted at 267.5p per share,
calculated at the closing middle market price derived from the Daily Official
List on 31 March 2008.

Non-executive      Value of remuneration used to      Number of Ordinary Shares
director           purchase shares                    allotted

Dr. Albert
Fischer                                   £9,750.00                      3,644

Dr. Robert
Chanson                                   £3,437.50                      1,285

Thomas Isler                              £7,062.50                      2,640

Following the above allotments, the Company was notified today that, on 2 April
2008, Dr. Chanson sold 2,640 Ordinary Shares in an off-market transaction at a
price of 267.5p per Ordinary Share.

2)On 1 April 2008, the Company approved the allotment of 20,000 Ordinary Shares 
to John Brady following the vesting of shares awarded under the Company's 2007 
Long Term Incentive Plan. The consideration paid for the shares was 1p per share.

Following the above allotment, the Company was notified today that, on 2 April
2008, Mr. Brady sold 5,605 Ordinary Shares at a price of 275.5p per Ordinary
Share. Mr. Brady intends to use the sale proceeds to satisfy the tax liability
on the shares vesting under his LTIP award.

3)On 1 April 2008, the Company granted 33,333 Ordinary Shares to Stephen Weaver,
Finance Director, under the Company's 2007 Long Term Incentive Plan.

The shares will vest, subject to the satisfaction of certain objective
performance conditions in 2010, at the end of three years.

Following the above-mentioned allotments, transactions and grant, the beneficial
interests of the directors concerned in the Ordinary Share capital of the
Company are as shown below:

Name       Ordinary Share          Percentage of        Share      LTIPs
                  holding        issued Ordinary      Options
                                   Share capital                  



John               14,395                  0.03      1,200,000    200,000
Brady

Stephen               Nil                   N/A            Nil    125,000
Weaver

Dr. Albert
Fischer           154,736                  0.35        225,000       N/A

Dr. Robert
Chanson           135,166                  0.30        210,000       N/A

Thomas            409,294                  0.92        202,500       N/A
Isler

Application has been made for 27,569 Ordinary Shares (the 'New Shares') to be
admitted to trading on AIM and admission is expected to occur on 8 April 2008.
The New Shares will rank pari passu with the Company's existing Ordinary Shares.

Following admission of the New Shares, the total issued share capital of the
Company will be 44,736,798 Ordinary Shares, all of which have voting rights.

The above figure (44,736,798) may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify 
their interest in, or a change to their interest in, Plant Health Care plc under
the FSA's Disclosure and Transparency Rules.

2 April 2008

Andrew C. Wood FCIS
Company Secretary
020 8866 5702

Evolution Securities Limited                          Tavistock Communications
Tim Worlledge/Tim Redfern                             Jeremy Carey/Matt Ridsdale
Tel: [phone]                                    Tel: [phone]



                      This information is provided by RNS
            The company news service from the London Stock Exchange